Correlation Between Foghorn Therapeutics and Lipella Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Lipella Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Lipella Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Lipella Pharmaceuticals Common, you can compare the effects of market volatilities on Foghorn Therapeutics and Lipella Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Lipella Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Lipella Pharmaceuticals.
Diversification Opportunities for Foghorn Therapeutics and Lipella Pharmaceuticals
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Foghorn and Lipella is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Lipella Pharmaceuticals Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipella Pharmaceuticals and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Lipella Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipella Pharmaceuticals has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Lipella Pharmaceuticals go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Lipella Pharmaceuticals
Given the investment horizon of 90 days Foghorn Therapeutics is expected to under-perform the Lipella Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Foghorn Therapeutics is 2.25 times less risky than Lipella Pharmaceuticals. The stock trades about -0.03 of its potential returns per unit of risk. The Lipella Pharmaceuticals Common is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 330.00 in Lipella Pharmaceuticals Common on August 30, 2024 and sell it today you would lose (35.00) from holding Lipella Pharmaceuticals Common or give up 10.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Foghorn Therapeutics vs. Lipella Pharmaceuticals Common
Performance |
| Timeline |
| Foghorn Therapeutics |
| Lipella Pharmaceuticals |
Foghorn Therapeutics and Lipella Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Foghorn Therapeutics and Lipella Pharmaceuticals
The main advantage of trading using opposite Foghorn Therapeutics and Lipella Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Lipella Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipella Pharmaceuticals will offset losses from the drop in Lipella Pharmaceuticals' long position.| Foghorn Therapeutics vs. Ikena Oncology | Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. HCW Biologics | Foghorn Therapeutics vs. RenovoRx |
| Lipella Pharmaceuticals vs. Senti Biosciences | Lipella Pharmaceuticals vs. Fennec Pharmaceuticals | Lipella Pharmaceuticals vs. Monopar Therapeutics | Lipella Pharmaceuticals vs. Akeso, Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |